Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2020-03-24

Clinical Trial Update: Study With Vortioxetine on Emotional Functioning in Patients With Depression [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating vortioxetine on emotional functioning in patients with major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vortioxetine (vortioxetine)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Major Depressive Disorder | Phase 4 | Status: COMPLETED